The Diabetic Kidney (eBook)
XVIII, 564 Seiten
Humana Press (Verlag)
978-1-59745-153-6 (ISBN)
A comprehensive and authoritative survey of recent findings, ideas, and hypotheses about the causes and treatment of diabetic nephropathy. The authors cover both the basic pathogenic mechanisms of the disease, as well as many of its clinical aspects of identification, management, and new therapeutic approaches. Highlights include an entire section devoted to novel approaches to studying diabetic nephropathy with the most advanced molecular techniques, and complete descriptions of the most up-to-date views on the diagnosis and treatment of the disease. The Diabetic Kidney offers both researchers and practicing clinicians a clear understanding of the of the progress that has been made regarding the pathogenesis of diabetic nephropathy and of the therapeutic interventions needed to prevent its development or treat it.
Part I: Basic Pathophysiology and Biochemistry of Diabetic Nephropathy
A. Pathophysiology
Angiotensin II and Its Receptors in the Pathogenesis of Diabetic Nephropathy
David J. Leehey, Ashok K. Singh, and Rekha Singh
Altered Renal Microvascular Function in Early Diabetes
Pamela K. Carmines, Joseph P. Bast, and Naohito Ishii
B. Interstitial Disease
Proteinuria and Interstitial Fibrogenesis in Diabetic Nephropathy
Raimund Hirschberg
C. Podocytes
Podocytes and Diabetic Nephropathy
George Jerums, Sianna Panagiotopoulos, and Richard MacIsaac
D. Altered Metabolic Pathways
Altered Glucose Transport and Its Metabolic Effects in Glomerular Cells
Charles W. Heilig
mRNA Translation in Diabetic Nephropathy
Balakuntalam S. Kasinath, Myung Ja Lee, Denis Feliers, and Nahum Sonenberg
The Hexosamine Biosynthesis Pathway: Contribution to the Pathogenesis of Diabetic Nephropathy
I. George Fantus, Howard J. Goldberg, Catharine I. Whiteside, and Delilah Topic
E. Nonenzymatic Glycosylation
Glycation: Receptor for Advanced Glycation Endproducts and Diabetic Nephropathy
Vivette D'Agati and Ann Marie Schmidt
F. Oxidative Stress
Oxidative and Glycooxidative Stress in Diabetic Nephropathy
Frederick R. DeRubertis and Patricia A. Craven
G. Growth Factors
Connective Tissue Growth Factor in the Pathogenesis of Diabetic Nephropathy: A Target for Therapeutic Intervention
Bruce L. Riser, Alessia Fornoni, and Sujatha Karoor
Vascular Endothelial Growth Factor as a Determinant of Diabetic Nephropathy
Geoffrey Boner and Mark E. Cooper
Transforming Growth Factor-b Signal Transduction in the Pathogenesis of Diabetic Nephropathy: Identifying Molecular Targets for Therapeutic Intervention
Sheldon Chen and Fuad N. Ziyadeh
H. New Approaches to the Study of Diabetic Nephropathy
Hepatocyte Growth Factor: Physiological and Therapeutic Ligand to Attenuate Diabetic Nephropathy
Shinya Mizuno and Toshikazu Nakamura
Proteomics in the Investigation of Diabetic Nephropathy
Visith Thongboonkerd
Gene Expression Profiling in the Investigation of Diabetic Nephropathy
Katalin Susztak, Erwin Bottinger, and Kumar Sharma
PPAR-g Ligands and Diabetic Nephropathy
Keiji Isshiki, Daisuke Koya, and Masakazu Haneda
a-Endosulfine in Diabetic Nephropathy
Jerry Yee and Balazs Szamosfalvi
The Prospect of a Novel Therapeutic, Bone Morphogenetic Protein-7, in Diabetic Nephropathy
Keith A. Hruska, Laura DePetris, Tingting Li, Song Wang, Theresa Geurs, Frank Strebeck, Qing Chen, and Helen Liapis
Part II: Clinical Aspects of Diabetic Nephropathy
A. Genetics and Risks
Genetic Determinants of Diabetic Nephropathy in Type 2 Diabetes
Grzegorz Placha and Andrzej S. Krolewski
Major Risk Indicators for Diabetic Kidney Disease
Katherine R. Tuttle
B. Histopathology and Special Populations
The Structure of Human Diabetic Nephropathy
Michael Mauer and Behzad Najafian
Diabetic Kidney Disease in Transitional and Disadvantaged Populations
E. Jennifer Weil and Robert G. Nelson
C. Diagnosis and Treatment
Screening and Treatment of Early Diabetic Renal Disease in Type 1 and Type 2 Diabetes
Ellie Chuang and Mark E. Molitch
Treatment in Advanced Renal Disease in Type 1 and Type 2 Diabetes
Eberhard Ritz and Gunter Wolf
Diabetic and Renal Disease: ACE Inhibitors and/or Angiotensin Receptor Blockers: Does It Matter?
Carl Erik Mogensen and Niels Holmark Andersen
Management of Diabetic End-Stage Renal Disease With Dialysis
Ploumis S. Passadakis and Dimitrios G. Oreopoulos
D. Rela
| Erscheint lt. Verlag | 6.11.2007 |
|---|---|
| Reihe/Serie | Contemporary Diabetes | Contemporary Diabetes |
| Zusatzinfo | XVIII, 564 p. 132 illus. |
| Verlagsort | Totowa |
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Diabetologie |
| Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie | |
| Schlagworte | biosynthesis • Diabetes • growth • Growth factor • kidney • Protein • signal transduction |
| ISBN-10 | 1-59745-153-3 / 1597451533 |
| ISBN-13 | 978-1-59745-153-6 / 9781597451536 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 8,8 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
